BNP/PUT/AMGEN/300/0.1/17.01.25 | Market Closed - Deutsche Boerse AG 20:50:28 27/06/2024 BST | ||
| 1.71 EUR | +1.18% |
|
| Current month | -22.62% | ||
| 1 month | -16.99% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
AMGEN INC.
| Date | Price | Change |
|---|---|---|
| 27/06/24 | 1.71 | +1.18% |
| 26/06/24 | 1.69 | +13.42% |
| 25/06/24 | 1.49 | -6.88% |
| 24/06/24 | 1.6 | -13.04% |
| 21/06/24 | 1.84 | -2.65% |
Delayed Quote Deutsche Boerse AG
Last update June 27, 2024 at 08:50 pm
More quotesStatic data
| Product type | Plain-Vanilla-Warrants |
|---|---|
| Buy / Sell | PUT |
| Underlying | AMGEN INC. |
| Issuer | 
BNP Paribas
|
| WKN | PN6Z76 |
| ISIN | DE000PN6Z761 |
| Date issued | 11/08/2023 |
| Strike | 300 $ |
| Maturity | 17/01/2025 (204 Days) |
| Parity | 10 : 1 |
| Emission price | 3.91 € |
| Emission volume | N/A |
| Settlement | Barausgleich |
| Currency | EUR |
Technical Indicators
| Highest since issue | 5.3 € |
|---|---|
| Lowest since issue | 1.37 € |
| Spread | 0.02 € |
| Spread % | 1.18% |
Company Profile
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows:
- drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.;
- other (5.8%): primarily royalties.
The United States account for 70.3% of net sales.
Sector
-
Consensus: Amgen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
313.7
USD
Average target price
316.4
USD
Spread / Average Target
+0.88%
- Stock Market
- Warrants
- Warrant
